BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22111837)

  • 1. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective.
    Wong CK; Lam CL; Poon JT; McGhee SM; Law WL; Kwong DL; Tsang J; Chan P
    J Eval Clin Pract; 2012 Dec; 18(6):1203-10. PubMed ID: 22111837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical cost associated with colorectal cancer in north of Jordan.
    Alefan Q; Malhees R; Mhaidat N
    Curr Probl Cancer; 2017; 41(5):371-381. PubMed ID: 28629637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
    Delcò F; Egger R; Bauerfeind P; Beglinger C
    Aliment Pharmacol Ther; 2005 Mar; 21(5):615-22. PubMed ID: 15740546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
    Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
    Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer.
    Howard DH; Tangka FK; Seeff LC; Richardson LC; Ekwueme DU
    Health Econ; 2009 Dec; 18(12):1381-93. PubMed ID: 19142856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of care for colorectal cancer in Ireland: a health care payer perspective.
    Tilson L; Sharp L; Usher C; Walsh C; S W; O'Ceilleachair A; Stuart C; Mehigan B; John Kennedy M; Tappenden P; Chilcott J; Staines A; Comber H; Barry M
    Eur J Health Econ; 2012 Aug; 13(4):511-24. PubMed ID: 21638069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China.
    Shen L; Li Q; Wang W; Zhu L; Zhao Q; Nie Y; Zhu B; Ma D; Lin X; Cai X; Fang W; Peng C; Chen Y; Fang H; Yin Z; Li H; Wang N; Xu R
    J Med Econ; 2020 May; 23(5):456-463. PubMed ID: 31950863
    [No Abstract]   [Full Text] [Related]  

  • 16. Lifetime costs of colon and rectal cancer management in Canada.
    Maroun J; Ng E; Berthelot JM; Le Petit C; Dahrouge S; Flanagan WM; Walker H; Evans WK
    Chronic Dis Can; 2003; 24(4):91-101. PubMed ID: 14733758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing medical care by disease phase in metastatic colorectal cancer.
    Song X; Zhao Z; Barber B; Gregory C; Schutt D; Gao S
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP20-5. PubMed ID: 21711074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
    Techawathanawanna S; Nimmannit A; Akewanlop C
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receipt of recommended therapy by patients with advanced colorectal cancer.
    Abraham NS; Gossey JT; Davila JA; Al-Oudat S; Kramer JK
    Am J Gastroenterol; 2006 Jun; 101(6):1320-8. PubMed ID: 16771956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD; Berry K; Etzioni R
    Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.